Drug Houses of Australia (Asia)

Drug Houses of Australia (Asia) is a leading pharmaceutical manufacturer and distributor based in Singapore, operating as a wholly-owned subsidiary of Haw Par Corporation. The company specializes in a wide range of generic medicines and over-the-counter (OTC) products, covering therapeutic areas such as pain management, dermatology, and respiratory health. DHA (Asia) maintains a high-standard, GMP-certified manufacturing facility in Singapore, which produces various dosage forms including tablets, capsules, liquids, and ointments. In addition to its own branded generics, the company provides comprehensive contract manufacturing (CMO) services to international pharmaceutical firms. With a legacy dating back to the 1960s, DHA (Asia) has established itself as a trusted provider of affordable healthcare solutions across the Asia-Pacific region.